NVO vs AAPL: Which Stock is Better?

Side-by-side comparison of Novo Nordisk A S and Apple Inc in 2026

Comparison Updated:

NVO

Novo Nordisk A S

$38.50

AAPL

Apple Inc

$260.22

Key Metrics Comparison

MetricNVOAAPLWinner
Market Cap$162.95BN/ANVO
P/E Ratio10.1333.85NVO
EPS (TTM)$3.62$7.55AAPL
Revenue Growth-0.1%6.4%AAPL
Gross Margin82.4%46.9%NVO

Analyze NVO

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is NVO or AAPL a better investment?

Comparing NVO and AAPL: Novo Nordisk A S has a market cap of $162.95B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between NVO and AAPL?

NVO (Novo Nordisk A S) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: NVO or AAPL?

Based on P/E ratios, NVO trades at a lower multiple (10.1x vs 33.8x).

Which is growing faster: NVO or AAPL?

AAPL has higher revenue growth at 6.4% vs -0.1% for NVO.

Which company is more profitable: NVO or AAPL?

Novo Nordisk A S (NVO) has higher gross margins at 82.4% compared to 46.9% for AAPL.

Which is the larger company: NVO or AAPL?

Novo Nordisk A S (NVO) is larger with a market cap of $162.95B compared to N/A for AAPL.

Should I buy NVO or AAPL in 2026?

Both NVO and AAPL have investment merit. NVO trades at $38.50 while AAPL trades at $260.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between NVO and AAPL stock?

Key differences: Market Cap ($162.95B vs N/A), P/E Ratio (10.1x vs 33.8x), Revenue Growth (-0.1% vs 6.4%), Gross Margin (82.4% vs 46.9%).

Popular Stock Comparisons